Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-27 Sale | 2024-02-27 7:54 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,405 | $0.7322 | $2,493 | 136,750 (Direct) | View |
| 2023-11-30 Purchase | 2023-12-04 4:54 pm | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 100,000 | $0.49362 | $49,362 | 100,000 (Direct) | View |
| 2023-11-28 Sale | 2023-11-28 7:06 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,720 | $0.5 | $1,860 | 140,155 (Direct) | View |
| 2023-08-28 Sale | 2023-08-29 6:47 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,512 | $1.45 | $5,092 | 143,875 (Direct) | View |
| 2023-05-25 Sale | 2023-05-26 7:29 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,635 | $1.4196 | $5,160 | 147,387 (Direct) | View |
| 2023-02-27 Sale | 2023-02-28 6:28 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,156 | $1.6812 | $3,625 | 85,233 (Direct) | View |
| 2023-02-27 Sale | 2023-02-28 6:22 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,599 | $1.6812 | $6,051 | 151,022 (Direct) | View |
| 2022-11-28 Sale | 2022-11-29 5:33 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,532 | $2.7196 | $9,606 | 154,621 (Direct) | View |
| 2022-11-28 Sale | 2022-11-29 5:25 pm | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,116 | $2.7193 | $5,754 | 87,389 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-22 4:07 pm | N/A 2032-11-14 | Viracta Therapeutics Inc. | VIRX | Burcar Melody Senior VP, Finance | 0 | $0 | 260,750 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-13 8:36 pm | N/A 2034-03-12 | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 475,000 | $0 | 475,000 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-13 8:33 pm | N/A 2034-03-12 | Viracta Therapeutics Inc. | VIRX | Cohen Darrel P. Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-13 8:29 pm | N/A 2034-03-12 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-25 Exercise | 2024-02-27 7:58 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2024-02-25 Exercise | 2024-02-27 7:56 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2024-02-25 Exercise | 2024-02-27 7:54 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 136,750 (Direct) | View |
| 2023-11-25 Exercise | 2023-11-28 7:06 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 140,155 (Direct) | View |
| 2023-11-25 Exercise | 2023-11-28 7:03 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-11-25 Exercise | 2023-11-28 7:01 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2023-08-25 Exercise | 2023-08-29 6:52 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-08-25 Exercise | 2023-08-29 6:49 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2023-08-25 Exercise | 2023-08-29 6:47 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,888 | $0 | 143,875 (Direct) | View |
| 2023-08-16 Option Award | 2023-08-18 4:51 pm | N/A 2033-08-16 | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-16 Option Award | 2023-08-18 4:46 pm | N/A 2033-08-16 | Viracta Therapeutics Inc. | VIRX | Cohen Darrel P. Chief Medical Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:49 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:41 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:34 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:28 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:26 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:22 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:19 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Chung Jane Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:13 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:11 pm | N/A 2033-06-08 | Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-05-25 Exercise | 2023-05-26 7:32 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-05-25 Exercise | 2023-05-26 7:30 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,035 | $0 | 144,547 (Direct) | View |
| 2023-05-25 Exercise | 2023-05-26 7:29 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 147,387 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-17 5:05 pm | N/A 2033-03-16 | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-17 5:03 pm | N/A 2033-03-16 | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-17 4:57 pm | N/A 2033-03-16 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-02-25 Exercise | 2023-02-28 6:30 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |
| 2023-02-25 Exercise | 2023-02-28 6:28 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,127 | $0 | 85,233 (Direct) | View |
| 2023-02-25 Exercise | 2023-02-28 6:25 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2023-02-25 Exercise | 2023-02-28 6:22 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 151,022 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:33 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 154,621 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:25 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 4,127 | $0 | 87,389 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:21 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 9,034 | $0 | 144,547 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:18 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director | 25,219 | $0 | 908,778 (Direct) | View |